Hims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低_老虎社区_美港股上老虎

Hims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低

新浪财经02-24

来源：环球市场播报远程医疗平台Hims & Hers Health最新季度销售额上升，该公司持续扩充治疗项目范围，订阅用户数量也有所增长。尽管这家远程医疗平台预计今年增长势头将延续，但其第一季度业绩指引低于华尔街预期。截至当日收盘，其股价在过去一年累计下跌69.8%。这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims &...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2613560764?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-24 13:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2613560764","market":"us","top_or_hot":-1,"title":"Hims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低","media":"新浪财经","content":"<div>\n<p>来源：环球市场播报远程医疗平台Hims & Hers Health最新季度销售额上升，该公司持续扩充治疗项目范围，订阅用户数量也有所增长。尽管这家远程医疗平台预计今年增长势头将延续，但其第一季度业绩指引低于华尔街预期。截至当日收盘，其股价在过去一年累计下跌69.8%。这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims &...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-24 13:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>来源：环球市场播报远程医疗平台Hims & Hers Health最新季度销售额上升，该公司持续扩充治疗项目范围，订阅用户数量也有所增长。尽管这家远程医疗平台预计今年增长势头将延续，但其第一季度业绩指引低于华尔街预期。截至当日收盘，其股价在过去一年累计下跌69.8%。这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims &...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b","article_id":"2613560764","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2613560764","pubTimestamp":1771912452,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims & Hers侵犯司美格鲁肽相关专利，而Hims & Hers则批评该诉讼是在打压平价药物选择。Hims & Hers的减重业务是其发展关键。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4196":"保健护理服务","HIYY":"YieldMax HIMS Option Income Strategy ETF","HIMY":"Defiance Leveraged Long + Income HIMS ETF","HIMS":"Hims & Hers Health Inc.","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF"},"translate_title":"Hims & Hers Health Fourth-quarter sales rose, but expectations for first-quarter results were low","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMZ":0.6,"HIMY":0.6,"HIMS":1.97,"HMYY":0.6,"HIYY":0.6},"content_text":"来源：环球市场播报远程医疗平台Hims & Hers Health最新季度销售额上升，该公司持续扩充治疗项目范围，订阅用户数量也有所增长。尽管这家远程医疗平台预计今年增长势头将延续，但其第一季度业绩指引低于华尔街预期。截至当日收盘，其股价在过去一年累计下跌69.8%。这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims & Hers侵犯司美格鲁肽相关专利，而Hims & Hers则批评该诉讼是在打压平价药物选择。本月早些时候，美国联邦卫生机构还将Hims & Hers移交至司法部，因其涉嫌违反《联邦食品、药品和化妆品法案》。Hims & Hers的减重业务是其发展关键。在诺和诺德的Wegovy、礼来的Mounjaro与Zepbound供应短缺期间，该公司获准大规模生产复方GLP‑1类药物，助力其人气快速提升。随着药物短缺问题缓解，Hims & Hers正加速拓展业务品类，包括去年推出激素疗法与实验室检测服务。该公司也在推进全球布局，上周宣布以11.5亿美元收购数字健康企业 Eucalyptus，计划借此进入澳大利亚、日本市场，并扩大在英国、德国和加拿大的业务规模。在财报电话会议上，公司首席执行官Dudum重点介绍了上述扩张举措，同时淡化公司对减重业务的依赖。Dudum表示，GLP‑1类药物确实为业务增长提供了显著助力，但这类药物只是其全球化消费平台中单一领域的单一疗法，而随着持续投入，该平台正变得更加强健、多元。他称，Hims & Hers仅有一小部分订阅用户使用复方GLP‑1类药物，这表明平台的影响力远不止于减重领域。他补充道，尽管并非所有新业务都能达到减重业务的增长速度，但凭借超级碗广告后用户接受度的快速提升，公司有信心睾酮治疗、更年期护理及检测服务业务在不久的将来年营收均突破1亿美元。“这三大新业务板块不只是新增服务，更是我们与客户建立更深度联结、创造更多价值的起点。”Dudum表示，公司未来还将拓展体能提升、身体恢复、睡眠管理等领域的服务，并持续推进国际化布局。周一，Hims & Hers公布季度利润2060万美元，合每股收益8美分；去年同期利润2600万美元，合每股11美分。FactSet调查的分析师平均预期为每股4美分。营收同比增长28%，至6.178亿美元，略低于分析师预期的6.192亿美元。这家总部位于旧金山的公司拥有250万订阅用户，同比增长13%；每用户月均营收增长11%，至83美元。公司预计第一季度营收为6亿至6.25亿美元，低于分析师预期的6.531亿美元。全年营收指引为27亿至29亿美元，分析师平均预期为27.4亿美元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}